These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9266226

  • 21. Human chorionic gonadotropin-positive seminoma: is this a special type of seminoma with a poor prognosis?
    Scheiber K, Mikuz G, Frommhold H, Bartsch G.
    Prog Clin Biol Res; 1985; 203():97-104. PubMed ID: 3832120
    [Abstract] [Full Text] [Related]

  • 22. [Significance of serum ferritin level in testicular tumors].
    Takai K, Kojima H, Kume H, Takemura T, Moriyama N, Murahashi I, Aso Y.
    Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
    [Abstract] [Full Text] [Related]

  • 23. Elevated human chorionic gonadotropin concentrations in the testicular vein and in peripheral venous blood in seminoma patients. An analysis of various parameters.
    Hartmann M, Pottek T, Bussar-Maatz R, Weissbach L.
    Eur Urol; 1997 Apr; 31(4):408-13. PubMed ID: 9187899
    [Abstract] [Full Text] [Related]

  • 24. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Morris MJ, Bosl GJ.
    J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta HCG).
    Munro AJ, Nielsen OS, Duncan W, Sturgeon J, Gospodarowicz MK, Malkin A, Thomas GM, Jewett MA.
    Br J Cancer; 1991 Sep; 64(3):537-42. PubMed ID: 1716953
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The utility of microscopic findings and immunohistochemistry in the classification of necrotic testicular tumors: a study of 11 cases.
    Miller JS, Lee TK, Epstein JI, Ulbright TM.
    Am J Surg Pathol; 2009 Sep; 33(9):1293-8. PubMed ID: 19461507
    [Abstract] [Full Text] [Related]

  • 32. Serum and tissue tumour markers in seminomas.
    Ford TF, Butcher DN, Samuell CT, Masters JR, Parkinson MC, Oliver RT.
    Br J Urol; 1985 Dec; 57(6):750-4. PubMed ID: 2417651
    [Abstract] [Full Text] [Related]

  • 33. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC, McBride LC.
    Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
    [Abstract] [Full Text] [Related]

  • 34. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G.
    J Clin Oncol; 2019 Jun 01; 37(16):1412-1423. PubMed ID: 30875280
    [Abstract] [Full Text] [Related]

  • 35. Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance.
    von Eyben FE, Madsen EL, Blaabjerg O, Petersen PH, Jacobsen GK, Specht L, Pedersen BN, von der Maase H.
    Acta Oncol; 2002 Jun 01; 41(1):77-83. PubMed ID: 11990523
    [Abstract] [Full Text] [Related]

  • 36. Placental alkaline phosphatase as a tumor marker for seminoma.
    Lange PH, Millan JL, Stigbrand T, Vessella RL, Ruoslahti E, Fishman WH.
    Cancer Res; 1982 Aug 01; 42(8):3244-7. PubMed ID: 7093962
    [Abstract] [Full Text] [Related]

  • 37. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD, Foster RS, Bihrle R, Donohue JP.
    Urology; 2007 Mar 01; 69(3):557-9. PubMed ID: 17382165
    [Abstract] [Full Text] [Related]

  • 38. Tumor markers in testicular germ cell tumors related to the stage of the disease at the time of diagnosis.
    Jacobsen GK.
    Oncodev Biol Med; 1983 Mar 01; 4(6):C39-44. PubMed ID: 6196749
    [Abstract] [Full Text] [Related]

  • 39. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM, Escaf Barmadah S, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, García Rodríguez J, Rodríguez Faba O, Jalón Monzón A, Rodríguez Martínez JJ.
    Arch Esp Urol; 2002 Oct 01; 55(8):927-36. PubMed ID: 12455283
    [Abstract] [Full Text] [Related]

  • 40. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T, Kamoto T, Hara I, Kawai K, Nakao M, Nonomura N, Kobayashi T, Ogawa O, Kamidono S, Akaza H, Okuyama A, Kato T, Miki T.
    Cancer; 2003 Oct 15; 98(8):1635-42. PubMed ID: 14534879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.